The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Cytek Biosciences sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Cytek Biosciences Inc (Cytek) is a cell analysis solutions company that focuses on advancing cell analysis tools through its patented full spectrum profiling (FSP) technology. The company’s main activities carries out harnessing the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with exquisite sensitivity. Cytek’s products include its core instruments, the aurora and northern lights systems, the aurora cs cell sorter, reagents and software. It’s products and services find applications for immuno-oncology, infectious diseases, inflammatory diseases, drug discovery, genomics and immune profiling. The company operates through its subsidiaries in the Netherlands, Japan and China. Cytek is headquartered in Fremont, California, USA. Key subsidiaries of Cytek Biosciences include Cytek Japan, Cytek Biosciences, Cytek (Shanghai) Software Development Technology, Cytek (Wuxi) BioSciences and Cytek (Shanghai) BioSciences.
The key metrics of Cytek Biosciences related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Cytek Biosciences is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Cytek Biosciences.
For a detailed understanding of the performance of Cytek Biosciences, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
